Lupus Landmark Study: A Prospective Registry and Biorepository
Part of paid clinical trials in Birmingham, Alabama.
- Sponsor
- Lupus Research Alliance
- Study ID
- NCT05934149
- Status
- Recruiting
Conditions
- Lupus Nephritis
- Neuropsychiatric Systemic Lupus Erythematosus
- Systemic Lupus Erythematosus (SLE)
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 110 Years
- Healthy Volunteers
- Not accepted
Study Details
The purpose of the registry and biorepository is to provide a mechanism to store clinical data, linked biospecimens and molecular data to support the conduct of future research on Systemic Lupus Erythematosus (SLE), including Lupus Nephritis (LN).
Key Dates
- Start date
- Jun 28, 2023
- Status verified
- Apr 2026
- Primary completion
- Dec 31, 2035
- Completion
- Dec 31, 2035
Study Design
- Enrollment
- 3,500 participants (estimated)
Arms
- Arm: New OnsetIndividuals with a new diagnosis of SLE
- Arm: LN ActiveIndividuals with a recent diagnosis of Lupus Nephritis
- Arm: Extra-renal FlareIndividuals who have experienced a recent flare
- Arm: PrevalentIndividuals with lupus who do not meet the criteria for one of the other cohorts
Primary Outcome Measure
Identify genetic drivers and antigenic targets, to elucidate mechanistic heterogeneity and correlate biomarkers to therapeutic responses. [ Time Frame: up to 25 years ]
Central Contacts
- Lupus Nexus Director646-884-6084
Locations (19)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Alabama at Birmingham | Birmingham | Alabama | 35205 | Christina Ndolo Jose Rubio Mosquera, MD (PRINCIPAL_INVESTIGATOR) |
| University of Arizona | Tucson | Arizona | 85714 | Lydia Benitez Kent Kwoh, MD (PRINCIPAL_INVESTIGATOR) |
| Wallace Rheumatic Studies Center | Beverly Hills | California | 90210 | Karla Alvarez Daniel Wallace, MD, FACP, MACR (PRINCIPAL_INVESTIGATOR) |
| UCLA | Los Angeles | California | 90024 | Maureen McMahon, MD (PRINCIPAL_INVESTIGATOR) |
| Georgetown University | Washington D.C. | District of Columbia | 20057 | Megan Lockwood, MD (PRINCIPAL_INVESTIGATOR) Virginia Steen, MD (SUB_INVESTIGATOR) Abraham Aron, MD (SUB_INVESTIGATOR) |
| University of Miami | Miami | Florida | 33146 | Luis Enrique Arias Mejia Niurka Colina Maria Carpintero, MD (PRINCIPAL_INVESTIGATOR) |
| Emory University | Atlanta | Georgia | 30322 | Kennedy Vela John Varghese Arezou Khosroshahi, MD (PRINCIPAL_INVESTIGATOR) |
| University of Chicago | Chicago | Illinois | 60637 | Rennan Ruivivar Yusra Irshad Kimberly Trotter, MD (PRINCIPAL_INVESTIGATOR) |
| Brigham and Women's Hospital | Boston | Massachusetts | 02115 | Elena Massarotti, MD (PRINCIPAL_INVESTIGATOR) Karen Costenbader, MD (SUB_INVESTIGATOR) |
| University of Massachusetts Memorial Health | Worcester | Massachusetts | 01605 | Chelsea Boateng Roberto Caricchio, MD (PRINCIPAL_INVESTIGATOR) |
| Washington University | St Louis | Missouri | 63130 | Maribel Chebuske Alfred Kim, MD, PhD (PRINCIPAL_INVESTIGATOR) Jessica Williams, MD, MPH (SUB_INVESTIGATOR) |
| The Feinstein Institutes for Medical Research | Manhasset | New York | 11030 | Andrew Shaw Meggan Mackay, MD, MS (PRINCIPAL_INVESTIGATOR) Cynthia Aranow, MD (SUB_INVESTIGATOR) |
| Columbia University Medical Center | New York | New York | 10032 | Stephen Suh Maria Ycaza Laura Geraldino-Pardilla, MD (PRINCIPAL_INVESTIGATOR) |
| Northwell Health | New York | New York | 11021 | Radha Puran Abdul Rehman Richard Furie, MD (PRINCIPAL_INVESTIGATOR) |
| SUNY Upstate | Syracuse | New York | 13210 | Carly Becker Andras Perl, MD, PhD (PRINCIPAL_INVESTIGATOR) |
| UNC Chapel Hill | Chapel Hill | North Carolina | 27599 | Anthony Trujillo Shruti Saxena Beem Saira Sheikh, MD (PRINCIPAL_INVESTIGATOR) |
| The MetroHealth System | Cleveland | Ohio | 44109 | Antoniy Fulmes Joe Finn Nora Singer, MD (PRINCIPAL_INVESTIGATOR) |
| Vanderbilt University Medical Center | Nashville | Tennessee | 37232 | Pamela Schlairet Narender Annapureddy, MD (PRINCIPAL_INVESTIGATOR) |
| UT Southwestern Medical Center | Dallas | Texas | 75390 | Nazeem Mohammed Serey Ol David Karp, MD (PRINCIPAL_INVESTIGATOR) Maria Bacalao, MD (SUB_INVESTIGATOR) |
Find similar trials in Birmingham, AL
By condition
By specialty
Related Studies
- Repository of Novel Analytes Leading to Autoimmune, Inflammatory and Diabetic Nephropathies (RENAL AID)Recruiting · The Rogosin Institute · New York, New York
- A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric ParticipantsPHASE2 · Recruiting · Hoffmann-La Roche · Loma Linda, California
- VIBRANT: VIB4920 for Active Lupus NephritisPHASE2 · Recruiting · National Institute of Allergy and Infectious Diseases (NIAID) · La Jolla, California
- Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- VPHASE2 · Recruiting · Novartis Pharmaceuticals · Phoenix, Arizona